uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Substance P endopeptidase-like activity is altered in various regions of the rat central nervous system during morphine tolerance and withdrawal
Uppsala University, Medicinska vetenskapsområdet, Faculty of Pharmacy, Department of Pharmaceutical Biosciences.
Show others and affiliations
2001 In: Neuropharmacology, Vol. 41, 246-253 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2001. Vol. 41, 246-253 p.
URN: urn:nbn:se:uu:diva-89564OAI: oai:DiVA.org:uu-89564DiVA: diva2:161152
Available from: 2001-11-22 Created: 2001-11-22Bibliographically approved
In thesis
1. The Impact of Substance P (SP) N-Terminal Metabolite SP1-7 in Opioid Tolerance and Withdrawal
Open this publication in new window or tab >>The Impact of Substance P (SP) N-Terminal Metabolite SP1-7 in Opioid Tolerance and Withdrawal
2001 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

The heptapeptide SP1-7, a metabolite of the neuroactive peptide substance P (SP), is suggested to play a role in opioid addiction and memory function. These two dimensions are known to involve dopamine and glutamate transmissions mediated through dopamine receptors and N-methyl-D- aspartate (NNMA) receptors, respectively. Research on interactions between SP1-7 and these two neurotransmitter systems may therefore be of importance to increase our understanding of the mechanisms behind opioid tolerance and dependence as well as memory processes. New knowledge in this area may lead to the discovery of new therapeutic routes for treatment of opioid addiction and other neuropsychiatric disorders, as well.

Studies described in this thesis include investigation of adaptive changes during morphine tolerance and withdrawal in brain levels of SP1-7 and in the activity of substance P endopeptidase (SPE), an enzyme responsible for the generation of this fragment. In morphine tolerant and abstinent rats, the SP1-7 level and SPE activity were significantly increased in discrete areas of the brain, which are crucial for the development of opioid tolerance and dependence. Furthermore, significant correlations between the SPE activity and some morphine withdrawal signs were observed. This finding was indicative of an endogenous modulatory mechanism involving both the enzyme and its active peptide product.

The effects of SP1-7 on the expression of morphine withdrawal and its interaction with dopaminergic pathways were examined in this thesis by behavioural tests, microdialysis as well as Northern blot and autoradiography techniques. Pre-treatment of morphine dependent rats with SP1-7 was found to stimulate dopamine release in nucleus accumbens and to inhibit the intensity of withdrawal behaviours. It was further shown to regulate both the dopamine D2 receptor gene transcript and the density of dopamine receptor proteins in mesolimbic dopamine pathways, confirming an interaction between SP1-7 and the dopamine system.

The influence of SP1-7 on glutamate transmission was investigated in morphine naive rats. The expression of the gene transcripts of the NMDA receptor subunits NR1, NR2A and NR2B was regulated in several brain regions involved in opioid withdrawal reactions and memory functions. The result is consistent with a possible decrease glutamate transmission in these areas.

It was concluded that SP1-7 may function as an endogenous modulator of the expression of opioid withdrawal by influencing both dopaminergic and glutamatergic transmission.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis, 2001. 60 p.
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, ISSN 0282-7484 ; 260
Pharmaceutical biosciences, Farmaceutisk biovetenskap
National Category
Pharmaceutical Sciences
Research subject
Pharmaceutical Biochemistry
urn:nbn:se:uu:diva-1551 (URN)91-554-5174-8 (ISBN)
Public defence
2001-12-14, Lecture Hall B42, Uppsala Biomedical Centre, Uppsala, 09:15
Available from: 2001-11-22 Created: 2001-11-22Bibliographically approved

Open Access in DiVA

No full text

By organisation
Department of Pharmaceutical Biosciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 38 hits
ReferencesLink to record
Permanent link

Direct link